VTAK — Catheter Precision Cashflow Statement
0.000.00%
Last trade - 00:00- $2.24m
- $5.43m
- $0.82m
Annual cashflow statement for Catheter Precision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.1 | -26.9 | -70.6 | -16.6 | -17.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -3.76 | 0.512 | 54.9 | 2.29 | 7.46 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.124 | 3.36 | -7.07 | -0.171 | 1.64 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -27.6 | -22.6 | -20.6 | -9.27 | -8.3 |
| Capital Expenditures | -0.265 | -0.017 | -0.076 | -0.067 | -0.133 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.07 | 0.038 | 0.015 | 0 | 0.3 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.8 | 0.021 | -0.061 | -0.067 | 0.167 |
| Financing Cash Flow Items | -0.64 | -1.25 | -0.64 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15 | 23.4 | 8.39 | 8.65 | 5.34 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.86 | 0.814 | -12.3 | -0.692 | -2.79 |